Haptoglobin Genotype– and Diabetes-Dependent Differences in Iron-Mediated Oxidative Stress In Vitro and In Vivo
暂无分享,去创建一个
A. Levy | R. Asleh | Julia Guetta | Shiri Kalet-Litman | R. Miller-Lotan | Andrew P. Levy | Rachel Miller-Lotan | Rabea Asleh | Julia Guetta | Shiri Kalet-Litman | R. Miller‐Lotan
[1] A. Roguin,et al. Haptoglobin type and 30-day mortality in diabetic individuals presenting with acute myocardial infarction. , 2003, Diabetes care.
[2] L. Hurley,et al. Iron stores are not associated with acute myocardial infarction. , 1994, Circulation.
[3] A Jacobs,et al. Low molecular weight intracellular iron transport compounds. , 1977, Blood.
[4] I. Hochberg,et al. Haptoglobin phenotype and vascular complications in patients with diabetes. , 2000, The New England journal of medicine.
[5] J. Delanghe,et al. Haptoglobin Polymorphism and Body Iron Stores , 2002, Clinical chemistry and laboratory medicine.
[6] H. Esterbauer,et al. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. , 1989, Journal of lipid research.
[7] Sudhir V. Shah,et al. Role of iron in atherosclerosis. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[8] M. Hediger,et al. Iron transport: emerging roles in health and disease. , 2002, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[9] M. D. De Buyzere,et al. Effect of haptoglobin on the metabolism of vitamin C. , 1997, The American journal of clinical nutrition.
[10] M. Kruszewski. The role of labile iron pool in cardiovascular diseases. , 2004, Acta biochimica Polonica.
[11] J. Sullivan. IRON AND THE SEX DIFFERENCE IN HEART DISEASE RISK , 1981, The Lancet.
[12] H. Bunn,et al. Exchange of heme among hemoglobins and between hemoglobin and albumin. , 1968, The Journal of biological chemistry.
[13] H. Ischiropoulos,et al. Evaluation of 2',7'-dichlorofluorescin and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells. , 1993, Archives of biochemistry and biophysics.
[14] J. Danesh,et al. Coronary heart disease and iron status: meta-analyses of prospective studies. , 1999, Circulation.
[15] D. Armaganijan,et al. Serum ferritin levels and other indicators of organic iron as risk factors or markers in coronary artery disease. , 2003, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.
[16] M. Linder,et al. Non-ferritin, non-heme iron pools in rat tissues. , 1986, The International journal of biochemistry.
[17] V. Bamm,et al. Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL. , 2004, Biochemistry.
[18] A. Kurosky,et al. Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutation. , 1982, Advances in human genetics.
[19] J. Keaney,et al. Iron Chelation Improves Endothelial Function in Patients With Coronary Artery Disease , 2001, Circulation.
[20] S. Altamentova,et al. Oxidation of low-density lipoprotein by hemoglobin stems from a heme-initiated globin radical: antioxidant role of haptoglobin. , 1997, Biochemistry.
[21] M B Khalifa,et al. BIACORE data processing: an evaluation of the global fitting procedure. , 2001, Analytical biochemistry.
[22] A. Kastrati,et al. Haptoglobin Genotype Is Predictive of Major Adverse Cardiac Events in the 1-year Period after Percutaneous Transluminal Coronary Angioplasty in Individuals with Diabetes , 2022 .
[23] J. Eaton,et al. Transition metals bind to glycated proteins forming redox active "glycochelates": implications for the pathogenesis of certain diabetic complications. , 1998, Biochemical and biophysical research communications.
[24] A. Joly,et al. Advanced glycosylation end products up-regulate connective tissue growth factor (insulin-like growth factor-binding protein-related protein 2) in human fibroblasts: a potential mechanism for expansion of extracellular matrix in diabetes mellitus. , 2001, Endocrinology.
[25] D. Giachetti,et al. Protection against oxidative damage of erythrocyte membrane by the flavonoid quercetin and its relation to iron chelating activity , 1997, FEBS letters.
[26] B. Halliwell,et al. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. , 1986, Archives of biochemistry and biophysics.
[27] F. Costantini,et al. Increased susceptibility in Hp knockout mice during acute hemolysis. , 1998, Blood.
[28] A. Ghio,et al. Pulmonary expression of the human haptoglobin gene. , 2000, American journal of respiratory cell and molecular biology.
[29] Haptoglobin polymorphism and peripheral arterial occlusive disease. , 1997 .
[30] D. Duprez,et al. Haptoglobin polymorphism and peripheral arterial occlusive disease. , 1997, Atherosclerosis.
[31] Z. Cabantchik,et al. Labile plasma iron in iron overload: redox activity and susceptibility to chelation. , 2003, Blood.
[32] W. Friedrichs,et al. Characterization of the mouse haptoglobin gene. , 1993, Genomics.
[33] A. Levy,et al. Genetically Determined Heterogeneity in Hemoglobin Scavenging and Susceptibility to Diabetic Cardiovascular Disease , 2003, Circulation research.
[34] D G Myszka,et al. Advances in surface plasmon resonance biosensor analysis. , 2000, Current opinion in biotechnology.
[35] J. Delanghe,et al. Biological and clinical significance of haptoglobin polymorphism in humans. , 1996, Clinical chemistry.
[36] Richard Earl Dickerson,et al. Hemoglobin : structure, function, evolution, and pathology , 1983 .
[37] D. Lehotay,et al. A biochemical, histochemical, and electron microscopic study on the effects of iron-loading on the hearts of mice. , 1999, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[38] M. Aviram,et al. Markers for low-density lipoprotein oxidation. , 2001, Methods in enzymology.
[39] E. Benjamin,et al. Haptoglobin phenotype and prevalent coronary heart disease in the Framingham offspring cohort. , 2004, Atherosclerosis.
[40] K. Jablonski,et al. Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study. , 2002, Journal of the American College of Cardiology.
[41] J. Gutteridge. Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides , 1986, FEBS letters.
[42] B. Howard,et al. The effect of vitamin therapy on the progression of coronary artery atherosclerosis varies by haptoglobin type in postmenopausal women. , 2004, Diabetes care.
[43] Leslie A. Smith,et al. Long-Term Vitamin C Treatment Increases Vascular Tetrahydrobiopterin Levels and Nitric Oxide Synthase Activity , 2003, Circulation research.
[44] S. Moestrup,et al. Identification of the haemoglobin scavenger receptor , 2001, Nature.
[45] B. Brozović. Iron transport and storage , 1976, Nature.
[46] B. Halliwell,et al. Formation of hydroxyl radicals from hydrogen peroxide in the presence of iron. Is haemoglobin a biological Fenton reagent? , 1988, The Biochemical journal.
[47] S. Panter. Release of iron from hemoglobin. , 1994, Methods in enzymology.